← FDA Drug Approvals (Drugs@FDA)

JAKAFI XR

NDA · New Drug Application · Sponsor: INCYTE CORP · Approved 2026-05-01

Drug application

FDA Application #

NDA217180

Application type

New Drug Application

Brand name

JAKAFI XR

Generic name

RUXOLITINIB

Active ingredients

RUXOLITINIB PHOSPHATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

INCYTE CORP

Manufacturer

Incyte Corporation

First approval

2026-05-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown